Open the mobile version, with barcode scanning
Class II Ongoing

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactu…

Why: Lack of assurance of Sterility:

Company
ACCORD BIOPHARMA INC
Raleigh, NC, United States
Reported
Jul 8, 2026
Recall started
Jun 10, 2026
Where sold
US Nationwide.
Amount
326 vials
Full product description
IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.
Lots / codes affected
Lot # 004L24A, Exp Date: 02/19/2027.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.